Deciding who should have thrombolysis
- 1 January 1994
- Vol. 308 (6920) , 59-60
- https://doi.org/10.1136/bmj.308.6920.59a
Abstract
EDITOR - K S Channer1 and other correspondents2 seem to misunderstand the results of clinical trials of thrombolytic agents. In 17 000 patients in the second international study of infarct survival (ISIS-2) the odds of dying were reduced by 25% by streptokinase compared with placebo (figure).3 With such large numbers the confidence intervals, which indicate where the “true” result is to be found with 95% certainty, are narrow. Odds ratios and 95% confidence intervals for death within 35 days after …Keywords
This publication has 1 reference indexed in Scilit: